Methyl iodide → HCID 90419149, compound
Reaction equation
[NH:1]1[CH:5]=[C:4]([CH2:6][N:7]([CH2:29][C:30]2[CH:35]=[CH:34][C:33]([O:36][CH3:37])=[CH:32][CH:31]=2)[C:8]2[C:9](=[O:28])[N:10]([CH3:27])[N:11]=[C:12]([O:14][CH2:15][C@H:16]3[CH2:18][C@@H:17]3[C:19]3[CH:24]=[CH:23][C:22]([O:25][CH3:26])=[CH:21][N:20]=3)[CH:13]=2)[N:3]=[N:2]1.[H-].[Na+].CI.[CH3:42]OC1C=CC(CN(CC2C=NN(C)N=2)C2C(=O)N(C)N=C(OC[C@H]3C[C@@H]3C3C=CC(OC)=CN=3)C=2)=CC=1>C1COCC1.O.CCOC(C)=O>[CH3:37][O:36][C:33]1[CH:34]=[CH:35][C:30]([CH2:29][N:7]([CH2:6][C:4]2[N:3]=[N:2][N:1]([CH3:42])[CH:5]=2)[C:8]2[C:9](=[O:28])[N:10]([CH3:27])[N:11]=[C:12]([O:14][CH2:15][C@H:16]3[CH2:18][C@@H:17]3[C:19]3[CH:24]=[CH:23][C:22]([O:25][CH3:26])=[CH:21][N:20]=3)[CH:13]=2)=[CH:31][CH:32]=1Participants
Procedure
To a solution of compound 2 (100 mg, 0.20 mmol) in THF (20 mL) was added NaH (12 mg, 0.30 mmol) at 0° C. After stirred for 10 min, MeI (57 mg, 0.40 mmol) was added. The mixture was stirred for 2 h at room temperature and then diluted with H2O (20 mL) and EtOAc (50 mL). The organic phase was washed with H2O and brine, dried over Na2SO4, filtered and concentrated. The residue was purified by prep-TLC using PE/EtOAc=4/1 to give 4-((4-methoxybenzyl)((1-methyl-1H-1,2,3-triazol-4-yl)methyl)amino)-6-(((1S,2S)-2-(5-methoxypyridin-2-yl)cyclopropyl)methoxy)-2-methylpyridazin-3(2H)-one (3) (55 mg, yield: 53%) as a yellow solid and 4-((4-methoxybenzyl)((2-methyl-2H-1,2,3-triazol-4-yl)methyl)amino)-6-(((1S,2S)-2-(5-methoxypyridin-2-yl)cyclopropyl)methoxy)-2-methylpyridazin-3(2H)-one (4). ESI-MS: 461.2 (M+H)+.
Workup
- stirringThe mixture was stirred for 2 h at room temperature
- washThe organic phase was washed with H2O and brine
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated
- customThe residue was purified by prep-TLC using PE/EtOAc=4/1
Sources & evidence
- ORD record
- ord-0a87bb8b48c444ef96eafdf402f6a338
- Source dataset
- uspto-grants-2016_05
- Patent number
- US09353104B2
Reaction notes
Loading…